female hormones

Product Profile: Misostrol 200 (Misoprostol 200mcg Tablets) Misostrol 200 contains a higher dose of Misoprostol (200mcg), a synthetic prostaglandin $E_1$ analogue. While low-dose misoprostol is used for labor induction, the 200mcg strength is primarily indicated for gastrointestinal protection and specific advanced obstetric/gynecological clinical protocols. 1. Clinical Indications & Usage NSAID-Induced Ulcer Prophylaxis: Indicated for the prevention of non-steroidal anti-inflammatory drug (NSAID)-induced gastric ulcers in patients at high risk of complications from gastric ulceration (e.g., elderly patients or those with a history of peptic ulcer disease). Obstetric/Gynecological Applications: Used in specialized clinical settings for the management of postpartum hemorrhage (PPH) or the medical management of pregnancy complications, strictly under hospital-based protocols. 2. Mechanism of Action Gastrointestinal Protection: Misoprostol replaces the protective prostaglandins depleted by NSAIDs. It exerts a dual effect: it inhibits gastric acid secretion (by acting on parietal cells) and enhances mucosal defense (by stimulating mucus and bicarbonate secretion and increasing mucosal blood flow). Myometrial Stimulation: As a prostaglandin analogue, it binds to prostanoid receptors on the myometrium, causing strong, coordinated uterine contractions. 3. Administration and Dosing Gastrointestinal Use: Typically administered orally at a dose of 200mcg, up to four times daily, with food. Professional Requirement: This is a high-alert medication. When used for obstetric/gynecological indications, administration must be performed exclusively by qualified healthcare professionals in a monitored inpatient setting. Precautions: Dosing must be strictly followed to avoid gastrointestinal side effects like diarrhea, which are common at this higher dose. ⚠️ Safety, Side Effects, and Monitoring Contraindications: Do not use in patients who are pregnant (when used for GI protection, as it can cause uterine contractions), those with a history of allergy to prostaglandins, or patients with a history of uterine rupture or major uterine surgery (for obstetric applications). Critical Warning: Misoprostol is a potent abortifacient and uterotonic. It must never be administered to a pregnant woman unless it is intended for a specific, supervised medical induction or pregnancy management protocol. Common Side Effects: Diarrhea (frequent), abdominal pain, nausea, flatulence, headache, and menstrual cramps (in non-pregnant women). 📦 Storage, Stability & Commercial Packaging Storage: Store in a cool, dry place at controlled room temperature (20°C to 25°C / 68°F to 77°F). Protection: Highly sensitive to humidity. Must be kept in original, hermetically sealed foil blister packaging until administration. Security: Keep under strict, restricted access to prevent misuse or unauthorized dispensing. PRESCRIPTION MEDICINE IS: YES. Disclaimer: This profile is compiled strictly for international wholesale procurement and commercial educational research. Misostrol 200 is a potent prescription medication and must be utilized strictly under the direct guidance of a licensed specialist. All cross-border importing setups must comply with the native health authorities and narcotics/pharmaceutical control laws of the destination country. 📞 Contact Ernest Impex — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Official Websites: www.ernestimpex.com www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com www.ernestvision.com 📧 Corporate Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 📲 WhatsApp Link: https://wa.me/919359902383

Product Profile: Second Step (Mifepristone 200mg + Misoprostol 200mcg)“ Second Step“ is a combination therapy kit containing Mifepristone (a progesterone receptor antagonist) and Misoprostol (a prostaglandin $E_1$ analogue). This combination is medically indicated for the management of specific obstetric and gynecological conditions, primarily for medical termination of pregnancy within established gestational limits. 1. Clinical Indications & Usage Medical Management of Pregnancy: The combination is used for the termination of intrauterine pregnancy up to a specific gestational age (typically within the first trimester), as determined by local clinical guidelines and regulatory health authorities. Mechanism of Coordination: Mifepristone: Functions by blocking the action of progesterone, the hormone essential for maintaining pregnancy. This leads to the detachment of the embryo from the uterine wall and increases the sensitivity of the uterus to prostaglandins. Misoprostol: Administered following Mifepristone, it stimulates uterine contractions and promotes cervical ripening, which facilitates the expulsion of the uterine content 2. Administration and Dosing Regimen: Treatment follows a strict, sequential protocol. Mifepristone is typically administered first, followed by Misoprostol after a specific interval (usually 24 to 48 hours), as prescribed by a healthcare provider. Professional Requirement: This combination must be utilized under the direct supervision of a licensed medical professional in a clinical setting. Patients must have access to emergency medical care throughout the process. ⚠️ Safety, Side Effects, and Monitoring Contraindications: Contraindicated in patients with a suspected ectopic pregnancy, chronic adrenal failure, inherited porphyria, hemorrhagic disorders, or those currently on anticoagulant therapy. It is also contraindicated if an intrauterine device (IUD) is in place. Critical Warnings: Risk of Incomplete Abortion: Patients must be monitored to ensure the procedure is complete. Incomplete expulsion may require surgical intervention (e.g., vacuum aspiration). Serious Infection: Although rare, severe bacterial infections, including sepsis, have been reported. Patients must be educated on warning signs (fever, severe abdominal pain). Common Side Effects: Abdominal cramping, vaginal bleeding, nausea, vomiting, diarrhea, and fever/chills. 📦 Storage, Stability & Commercial Packaging Storage: Store at controlled room temperature (20°C to 25°C / 68°F to 77°F). Protection: Keep in original blister packaging to protect from light and moisture. Misoprostol is particularly sensitive to humidity. Security: Keep under restricted, secure access to prevent unauthorized use. PRESCRIPTION MEDICINE IS: YES. Disclaimer: This profile is compiled strictly for international wholesale procurement and commercial educational research. Second Step is a potent prescription combination that must be utilized strictly under the direct guidance of a licensed specialist. All import, distribution, and clinical usage must adhere strictly to the laws, narcotics, and pharmaceutical control regulations of the destination country. Failure to comply with local medical legislation regarding the usage of this product can result in severe legal consequences 📞 Contact Ernest Impex — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Official Websites: www.ernestimpex.com www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com www.ernestvision.com 📧 Corporate Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 📲 WhatsApp Link: https://wa.me/919359902383

Product Profile: Misostrol 25mcg (Misoprostol Tablets) Misostrol contains Misoprostol, a synthetic prostaglandin $E_1$ analogue. At the low dose of 25mcg, it is primarily used in obstetric practice for cervical ripening and the induction of labor in patients at term. 1. Clinical Indications & Usage Obstetric Induction: Indicated for cervical ripening and induction of labor in pregnant women at or near term, when there is a medical necessity for induction and the cervix is favorable. Clinical Protocol: Its use is strictly regulated and reserved for hospital settings where fetal heart rate and uterine contractions can be continuously monitored. 2. Mechanism of Action Cervical Ripening: Misoprostol acts directly on the cervix to promote collagen degradation and increase ground substance, leading to cervical softening (ripening) and effacement. Uterine Stimulation: It stimulates the smooth muscle of the uterus, increasing the frequency and intensity of uterine contractions, which facilitates the progression of labor. 3. Administration and Dosing Route: Typically administered vaginally or orally, depending on specific institutional protocols and clinical guidelines. Professional Requirement: This is a high-alert medication that must be administered exclusively by qualified obstetricians or healthcare professionals in a monitored inpatient setting. Dosing: 25mcg is the standard low-dose initiation for labor induction to minimize the risk of uterine tachysystole. Dosing must be adjusted based on the patient’s cervical assessment (Bishop score) and uterine response. ⚠️ Safety, Side Effects, and Monitoring Contraindications: Do not use in patients with a history of previous cesarean sections or major uterine surgery (due to risk of uterine rupture), fetal distress, cephalopelvic disproportion, or unexplained vaginal bleeding. Critical Warning: The use of misoprostol can result in uterine tachysystole (hyperstimulation), which may lead to fetal distress, uterine rupture, or amniotic fluid embolism. Continuous fetal heart rate and uterine activity monitoring are mandatory. Common Side Effects: Nausea, vomiting, diarrhea, fever, and uterine hyperstimulation. 📦 Storage, Stability & Commercial Packaging Storage: Store in a cool, dry place at controlled room temperature (20°C to 25°C / 68°F to 77°F). Protection: Misoprostol is highly sensitive to moisture and humidity. Keep in the original, sealed foil blister packaging until the moment of use. Security: Keep under strict lock and key to prevent unauthorized access or misuse. PRESCRIPTION MEDICINE IS: YES. Disclaimer: This profile is compiled strictly for international wholesale procurement and commercial educational research. Misostrol is a potent prescription medication and must be utilized strictly in a clinical/hospital setting under direct obstetric supervision. All import and usage must adhere to the laws and medical regulations of the destination country. 📞 Contact Ernest Impex — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Official Websites: www.ernestimpex.com www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com www.ernestvision.com 📧 Corporate Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 📲 WhatsApp Link: https://wa.me/919359902383

Product Profile: Dydroloop (Dydrogesterone 10mg Tablets) Dydroloop contains Dydrogesterone, a synthetic progestogen that is structurally very similar to natural progesterone. It is highly valued in clinical practice due to its high selectivity for the progesterone receptor and its lack of androgenic, estrogenic, or glucocorticoid activity, making it an excellent choice for hormonal supplementation. 1. Clinical Indications & Usage Progesterone Deficiency: Indicated for the treatment of conditions related to endogenous progesterone deficiency, including threatened or recurrent miscarriage. Menstrual Disorders: Used to treat dysmenorrhea (painful periods), endometriosis, and secondary amenorrhea. Cycle Regulation: Effectively manages irregular menstrual cycles and dysfunctional uterine bleeding. Hormone Replacement Therapy (HRT): Often added to estrogen-only HRT regimens to provide essential endometrial protection in postmenopausal women. Infertility: Utilized in fertility treatments for luteal support to promote successful implantation. 2. Mechanism of Action Progesterone Receptor Selectivity: Dydrogesterone binds specifically to the progesterone receptor without the off-target side effects (such as acne or hirsutism) common with other synthetic progestins. Endometrial Transformation: It effectively converts the estrogen-primed endometrium into a secretory state, essential for implantation and the maintenance of pregnancy. Metabolic Neutrality: Because of its unique structure, it has a favorable safety profile regarding lipid metabolism and blood pressure, making it suitable for long-term use in HRT. 3. Administration and Dosing Regimen: Dosage varies widely based on the indication (e.g., daily dose for endometriosis vs. cyclical dose for cycle regulation). Administration: Tablets should be taken orally with water. Doses can be divided throughout the day if prescribed for higher-level support. Consistency: Adherence to the specific timing and duration recommended by the physician is critical for both cycle control and pregnancy maintenance. ⚠️ Safety, Side Effects, and Monitoring Contraindications: Do not use if the patient has undiagnosed vaginal bleeding, known hypersensitivity to Dydrogesterone, or severe hepatic impairment. Common Side Effects: Generally well-tolerated. Minor side effects may include headache, nausea, breast tenderness, or mild breakthrough bleeding during the initial cycles. Advantage: Dydrogesterone is noted for its lack of common progestin-related side effects such as weight gain, fluid retention, or mood swings. 📦 Storage, Stability & Commercial Packaging Storage: Store at controlled room temperature (20°C to 25°C / 68°F to 77°F). Protection: Keep in original blister packaging to protect from light and moisture. Security: Keep securely out of reach of children. PRESCRIPTION MEDICINE IS: YES. Disclaimer: This profile is compiled strictly for international wholesale procurement and commercial educational research. Dydroloop is a prescription medicine and must be utilized solely under the direct guidance of a registered medical specialist. All cross-border importing setups must comply with the native health authorities of the destination country. 📞 Contact Ernest Impex — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Official Websites: www.ernestimpex.com www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com www.ernestvision.com 📧 Corporate Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 📲 WhatsApp Link: https://wa.me/919359902383

Product Profile: Menoestra (Estradiol Valerate 2mg Tablets) Menoestra contains Estradiol Valerate, a synthetic ester of the natural human estrogen, 17$beta$-estradiol. It is a potent estrogen replacement therapy used to manage symptoms associated with menopause and other conditions caused by estrogen deficiency. 1. Clinical Indications & Usage Menopausal Hormone Therapy (MHT/HRT): Indicated for the treatment of moderate-to-severe vasomotor symptoms (hot flashes, night sweats) associated with menopause. Vulvar and Vaginal Atrophy: Used to treat symptoms of vulvar and vaginal atrophy occurring after menopause. Hypoestrogenism: Used for the treatment of hypoestrogenism due to hypogonadism, castration, or primary ovarian failure. Osteoporosis Prevention: Used in postmenopausal women to prevent osteoporosis, specifically in those at high risk of fractures who cannot take other non-estrogen treatments. 2. Mechanism of Action Hormonal Supplementation: Estradiol valerate acts as a prodrug; once absorbed, it is cleaved into natural 17$beta$-estradiol. It binds to estrogen receptors in target tissues, effectively restoring systemic estrogen levels to a pre-menopausal range. Physiological Regulation: By supplementing endogenous estrogen, it modulates the thermoregulatory center in the hypothalamus (reducing hot flashes) and promotes the proliferation of vaginal epithelium, thereby improving local atrophy symptoms. 3. Administration and Dosing Regimen: Treatment is typically initiated at the lowest effective dose. In women with an intact uterus, estrogen therapy must be combined with a progestogen to reduce the risk of endometrial cancer. Administration: Tablets should be taken orally with water, generally at the same time each day to maintain stable hormone levels. Consistency: Continuous or cyclical regimens (with or without a treatment-free interval) are determined by the prescribing physician based on individual clinical needs. ⚠️ Safety, Side Effects, and Monitoring Contraindications: Do not use in patients with undiagnosed vaginal bleeding, known/suspected breast cancer, estrogen-dependent tumors, active or history of venous thromboembolism (VTE), arterial thromboembolic disease (e.g., stroke, MI), or severe liver disease. Critical Warnings: Estrogen therapy is associated with increased risks of endometrial cancer (if used without a progestogen), cardiovascular disease, and venous thromboembolism. Common Side Effects: Breast tenderness, abdominal bloating, headache, nausea, weight changes, and spotting/breakthrough bleeding. 📦 Storage, Stability & Commercial Packaging Storage: Store at controlled room temperature (20°C to 25°C / 68°F to 77°F). Protection: Keep in original blister packaging to protect from light and moisture. Security: Keep securely out of reach of children . PRESCRIPTION MEDICINE IS: YES. Disclaimer: This profile is compiled strictly for international wholesale procurement and commercial educational research. Menoestra is a prescription medicine and must be utilized solely under the direct guidance of a registered medical specialist. All cross-border importing setups must comply with the native health authorities of the destination country. 📞 Contact Ernest Impex — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Official Websites: www.ernestimpex.com www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com www.ernestvision.com 📧 Corporate Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 📲 WhatsApp Link: https://wa.me/919359902383

Product Profile: Aromasten 25 (Exemestane 25mg Tablets) Aromasten 25 contains Exemestane, a potent, irreversible steroidal aromatase inactivator. Unlike non-steroidal aromatase inhibitors, Exemestane acts as a “suicide inhibitor,“ permanently binding to the aromatase enzyme and rendering it inactive, which results in a profound reduction of circulating estrogen levels in postmenopausal women. 1. Clinical Indications & Usage Breast Cancer Treatment: Indicated for the adjuvant treatment of postmenopausal women with estrogen receptor-positive early breast cancer who have received 2–3 years of tamoxifen therapy and are switched to exemestane to complete a total of 5 consecutive years of adjuvant hormonal therapy. Advanced Breast Cancer: Used for the treatment of advanced breast cancer in postmenopausal women whose disease has progressed following anti-estrogen (e.g., tamoxifen) therapy. 2. Mechanism of Action Irreversible Inhibition: Exemestane structurally mimics the substrate androstenedione. It binds to the active site of the aromatase enzyme, causing its permanent inactivation. Estrogen Depletion: Because the enzyme is permanently disabled, the body's peripheral conversion of androgens to estrogens is significantly blocked. In postmenopausal women, this is the primary source of estrogen, and its depletion effectively halts the growth of hormone-dependent breast cancer cells. 3. Administration and Dosing Regimen: The recommended dosage is 25mg taken orally once daily, preferably administered after a meal to enhance absorption. Consistency: It should be taken at the same time each day to maintain steady-state serum concentrations. Tablets must be swallowed whole. ⚠️ Safety, Side Effects, and Monitoring Contraindications: Not indicated for premenopausal women. Do not use in patients who are pregnant or breastfeeding. It should not be administered concurrently with estrogen-containing medications (e.g., HRT), as these will negate the drug’s efficacy. Important Considerations: Bone Health: By suppressing estrogen, Exemestane can accelerate bone loss, leading to a higher risk of osteoporosis and fractures. Bone mineral density (BMD) monitoring is standard clinical practice. Lipid Profile: May lead to increases in serum cholesterol and triglyceride levels. Common Side Effects: Hot flashes, fatigue, joint and muscle pain (arthralgia), nausea, increased sweating, insomnia, and headache. 📦 Storage, Stability & Commercial Packaging Storage: Store at controlled room temperature (20°C to 25°C / 68°F to 77°F). Protection: Keep in original blister packaging to protect from moisture and light. Security: Keep securely out of reach of children. PRESCRIPTION MEDICINE IS: YES. Disclaimer: This profile is compiled strictly for international wholesale procurement and commercial educational research. Aromasten 25 is a highly specialized prescription medication and must be utilized strictly under the supervision of a licensed oncologist or physician. All cross-border importing setups must comply with the native health authorities of the destination country. 📞 Contact Ernest Impex — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Official Websites: www.ernestimpex.com www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com www.ernestvision.com 📧 Corporate Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 📲 WhatsApp Link: https://wa.me/919359902383

Product Profile: Medroxy 10 (Medroxyprogesterone Acetate 10mg Tablets) Medroxy 10 contains Medroxyprogesterone Acetate (MPA), a synthetic progestin used in a wide range of gynecological and hormonal indications. Unlike the injectable depot form, the oral tablet provides a convenient method for managing conditions requiring cyclical or continuous progestogen supplementation. 1. Clinical Indications & Usage Secondary Amenorrhea: Indicated for the treatment of secondary amenorrhea (absence of menstrual cycles) in women with an intact uterus. Abnormal Uterine Bleeding: Used in the management of dysfunctional uterine bleeding caused by hormonal imbalance, often in conjunction with estrogen therapy. Endometrial Protection: Frequently prescribed to protect the uterine lining (endometrium) from hyperplasia in postmenopausal women receiving estrogen-only hormone replacement therapy (HRT). 2. Mechanism of Action Endometrial Regulation: Medroxyprogesterone Acetate mimics the actions of natural progesterone, transforming the proliferative endometrium into a secretory state. Pituitary Inhibition: It acts by inhibiting the release of gonadotropins (FSH and LH) from the pituitary gland, which suppresses follicular maturation and ovulation, thereby regulating the menstrual cycle. Progestogenic Activity: It exerts potent progestational effects with minimal androgenic or estrogenic side effects compared to other synthetic progestogens. 3. Administration and Dosing Regimen: Dosing is highly individualized depending on the clinical condition (e.g., whether it is being used for cycle induction or endometrial protection during HRT). Administration: Tablets should be taken orally with water. For best results in cycle management, it is critical to take the medication at the same time each day. Consistency: Adherence to the specific dosing schedule (cyclical or continuous) prescribed by the healthcare provider is essential for therapeutic success. ⚠️ Safety, Side Effects, and Monitoring Contraindications: Do not use if the patient has undiagnosed vaginal bleeding, known or suspected pregnancy, active thromboembolic disorders (e.g., DVT, PE), severe liver dysfunction, or known breast cancer. Common Side Effects: Breakthrough bleeding or spotting, breast tenderness, fatigue, headache, fluid retention, weight changes, and mood fluctuations. Monitoring: Patients with a history of depression, diabetes, migraine, or hypertension should be monitored closely, as progestogens may influence these conditions. 📦 Storage, Stability & Commercial Packaging Storage: Store at controlled room temperature (20°C to 25°C / 68°F to 77°F). Protection: Keep in original blister packaging to protect from light and moisture. Security: Keep securely out of reach of children. PRESCRIPTION MEDICINE IS: YES. Disclaimer: This profile is compiled strictly for international wholesale procurement and commercial educational research. Medroxy 10 is a prescription medicine and must be utilized solely under the direct guidance of a registered medical specialist. All cross-border importing setups must comply with the native health authorities of the destination country. 📞 Contact Ernest Impex — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Official Websites: www.ernestimpex.com www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com www.ernestvision.com 📧 Corporate Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 📲 WhatsApp Link: https://wa.me/919359902383

Product Profile: Tamofar 20mg (Tamoxifen Citrate Tablets) Tamofar 20mg contains Tamoxifen, a Selective Estrogen Receptor Modulator (SERM). It is a foundational medication in the treatment and prevention of hormone receptor-positive breast cancer, acting as a competitive antagonist of estrogen receptors in breast tissue. 1. Clinical Indications & Usage Breast Cancer Treatment: Indicated for the adjuvant treatment of hormone receptor-positive breast cancer in women (both pre- and postmenopausal) to reduce the risk of recurrence. It is also used in the treatment of metastatic breast cancer. Breast Cancer Prevention: Prescribed to reduce the risk of invasive breast cancer in women at high risk. Ductal Carcinoma in Situ (DCIS): Used to reduce the risk of invasive breast cancer following surgery and radiation for DCIS. 2. Mechanism of Action Tamoxifen functions through a tissue-specific modulation of estrogen receptors: Antiestrogenic Effect (Breast): By binding to estrogen receptors in the breast, it prevents estrogen from stimulating the growth of cancer cells, thereby effectively inhibiting tumor proliferation in ER-positive cases. Estrogenic Effect (Other Tissues): In other tissues, such as the endometrium and bone, Tamoxifen can exhibit estrogen-like (agonist) effects, which necessitates clinical monitoring for specific long-term health markers. 3. Administration and Dosing Regimen: The standard adult dose is typically 20mg per day. Duration: Treatment is often long-term, frequently spanning 5 to 10 years, as directed by an oncologist. Administration: Tablets should be taken orally with water, generally at the same time each day, with or without food. ⚠️ Safety, Side Effects, and Monitoring Contraindications: Do not use if there is a history of deep vein thrombosis (DVT) or pulmonary embolism (PE), if the patient is currently on anticoagulant therapy, or if the patient is pregnant. Critical Warnings: Endometrial Risks: Because of its potential agonist effects on the uterus, long-term use can increase the risk of endometrial cancer. Patients should report any abnormal vaginal bleeding immediately. Thromboembolic Risk: There is an increased risk of stroke, DVT, and PE, particularly in patients with existing risk factors. Common Side Effects: Hot flashes, vaginal discharge or bleeding, mood swings, nausea, fatigue, and leg cramps. 📦 Storage, Stability & Commercial Packaging Storage: Store at controlled room temperature (20°C to 25°C / 68°F to 77°F). Protection: Keep in original blister packaging to protect from light and moisture. Security: Keep securely out of reach of children and others to prevent accidental ingestion. PRESCRIPTION MEDICINE IS: YES. Disclaimer: This profile is compiled strictly for international wholesale procurement and commercial educational research. Tamofar is a specialized prescription medication and must be utilized strictly under the supervision of a licensed oncologist or physician. All import and usage must adhere to the laws and medical regulations of the destination country. 📞 Contact Ernest Impex — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Official Websites: www.ernestimpex.com www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com www.ernestvision.com 📧 Corporate Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 📲 WhatsApp Link: https://wa.me/919359902383

Product Profile: Norethis NCR (Norethisterone Acetate Controlled Release 10mg) Norethis NCR is a specialized high-dose, controlled-release formulation of Norethisterone Acetate (10mg). This dosage and release profile are designed for clinical conditions requiring sustained, therapeutic progestogenic levels for longer durations, effectively managing complex gynecological disorders. 1. Clinical Indications & Usage Severe Endometriosis: Indicated for the management of severe, symptomatic endometriosis where continuous progestogenic suppression is required to inhibit endometrial tissue growth. Complex Menstrual Disorders: Used for the treatment of intractable dysfunctional uterine bleeding and heavy menstrual loss where standard dosing is insufficient. Secondary Amenorrhea: Utilized in protocols to induce withdrawal bleeding in cases of profound hormonal deficiency or persistent cycles of non-responsiveness to lower-dose therapies. Breast Cancer (Palliative): In specific clinical scenarios, high-dose progestogens may be used for the palliative treatment of advanced, hormone-dependent breast cancer in postmenopausal women. 2. Mechanism of Action Enhanced Suppression: By delivering 10mg of Norethisterone Acetate in a controlled-release matrix, the formulation provides more uniform serum hormone levels, preventing the peaks and troughs associated with conventional tablets. This leads to more effective and predictable suppression of the pituitary-ovarian axis. Deep Endometrial Atrophy: The sustained delivery promotes a rapid and deep transformation of the endometrium, which is essential for stopping persistent uterine bleeding and atrophy of endometriotic lesions. Optimized Pharmacokinetics: The controlled-release mechanism ensures a steady state, potentially enhancing patient compliance and therapeutic efficacy for long-term suppressive therapy. 3. Administration and Dosing Regimen: The 10mg controlled-release dosage is reserved for specific therapeutic protocols. Treatment must be strictly managed by a specialist. Administration: Tablets must be swallowed whole with water. Do not crush, chew, or split the tablet, as doing so will disrupt the controlled-release delivery system, leading to a sudden release of the drug that may cause adverse reactions or loss of efficacy. Consistency: Adherence to the daily dosing schedule is critical for maintaining the therapeutic steady state. ⚠️ Safety, Side Effects, and Monitoring Contraindications: Prohibited in patients with active thromboembolic diseases (DVT, PE), undiagnosed vaginal bleeding, severe liver impairment, known pregnancy, or hormone-sensitive malignancies (unless specified for palliative cancer care). Common Side Effects: Higher-dose progestogens may result in more pronounced side effects, including significant fluid retention, weight gain, fatigue, breast tenderness, and mood changes (including depression). Clinical Monitoring: Patients on high-dose therapy require regular monitoring of blood pressure, liver function, and, in long-term therapy, lipid profiles. 📦 Storage, Stability & Commercial Packaging Storage: Store at room temperature (below 30°C / 86°F). Protection: Keep in original blister packaging to protect from moisture and light. Security: Keep securely out of reach of children and others to prevent unauthorized use PRESCRIPTION MEDICINE IS : YES. Disclaimer: This profile is compiled strictly for international wholesale procurement and commercial educational research. Norethis NCR is a high-dose prescription medicine and must be utilized strictly under the direct guidance of a registered medical specialist. All cross-border importing setups must comply with the native health authorities of the destination country. 📞 Contact Ernest Impex — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Official Websites: www.ernestimpex.com www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com www.ernestvision.com 📧 Corporate Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 📲 WhatsApp Link: https://wa.me/919359902383

Product Profile: Norethis-A 5 (Norethindrone Acetate 5mg) Norethis-A 5 contains Norethindrone Acetate, a potent synthetic progestogen. This compound is the acetate ester of norethindrone, which provides enhanced oral bioavailability and is widely utilized in therapeutic regimens for various gynecological conditions and hormonal replacement therapy. 1. Clinical Indications & Usage Endometriosis: Indicated for the treatment of moderate-to-severe endometriosis by suppressing ovarian function and inducing a hypo-estrogenic state that inhibits the growth of endometrial tissue. Secondary Amenorrhea & Abnormal Uterine Bleeding: Effectively used to manage hormonal imbalances causing irregular cycles, heavy menstrual bleeding (menorrhagia), or the absence of menstruation. Hormone Replacement Therapy (HRT): Often used in combination with estrogen in postmenopausal women to provide endometrial protection and prevent estrogen-induced hyperplasia. 2. Mechanism of Action Hormonal Suppression: Norethindrone Acetate acts on the hypothalamus-pituitary-ovarian axis to inhibit the secretion of gonadotropins (FSH and LH), preventing ovulation. Progestogenic Effect: It transforms the proliferative endometrium into a secretory state. With continuous use, it inhibits the growth of endometrial implants (in cases of endometriosis) and reduces the thickness of the uterine lining (in cases of menorrhagia). Bioavailability: The acetate ester structure ensures superior absorption and efficacy when administered orally, making it a reliable choice for consistent hormonal management. 3. Administration and Dosing Regimen: Dosage is highly dependent on the indication (e.g., daily cycling or continuous therapy for endometriosis). It must be strictly tailored to the clinical diagnosis and patient response. Administration: Tablets should be taken orally at the same time each day to maintain steady therapeutic serum levels. Consistency: Continuous administration is often required for conditions like endometriosis to achieve sustained symptom suppression. ⚠️ Safety, Side Effects, and Monitoring Contraindications: Do not use in patients with active thrombophlebitis or thromboembolic disorders, undiagnosed vaginal bleeding, known or suspected breast cancer, hepatic dysfunction, or pregnancy. Common Side Effects: Breakthrough bleeding or spotting (especially during early treatment), breast tenderness, fluid retention, headache, weight fluctuations, mood changes, and gastrointestinal discomfort. Cautionary Note: Patients with a history of depression, diabetes, migraine, or hypertension should be closely monitored, as progestogens may influence these conditions. 📦 Storage, Stability & Commercial Packaging Storage: Store at controlled room temperature (20°C to 25°C / 68°F to 77°F). Protection: Keep in original packaging to protect from light and moisture. Security: Keep securely out of reach of children. PRESCRIPTION MEDICINE IS : YES. Disclaimer: This profile is compiled strictly for international wholesale procurement and commercial educational research. Norethis-A 5 is a prescription medicine and must be utilized solely under the direct guidance of a registered medical specialist. All cross-border importing setups must comply with the native health authorities of the destination country. 📞 Contact Ernest Impex — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Official Websites: www.ernestimpex.com www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com www.ernestvision.com 📧 Corporate Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 📲 WhatsApp Link: https://wa.me/919359902383

Product Profile: Norethis 5mg (Norethisterone Tablets) Norethis 5mg contains Norethisterone, a synthetic progestogen with a broad range of gynecological applications. It is frequently used to manage menstrual cycle disorders, endometriosis, and as an effective tool for cycle delay. 1. Clinical Indications & Usage Menstrual Cycle Regulation: Indicated for the treatment of irregular menstrual cycles, heavy menstrual bleeding (menorrhagia), and dysmenorrhea (painful menstruation). Endometriosis: Used to manage symptoms of endometriosis by inducing a state of pseudopregnancy or suppressing the menstrual cycle. Cycle Delay: Often used to postpone menstruation for personal or clinical reasons by delaying the onset of the withdrawal bleed. Premenstrual Syndrome (PMS): Used to alleviate severe symptoms associated with the premenstrual phase. 2. Mechanism of Action Hormonal Suppression: Norethisterone acts on the pituitary gland to inhibit the release of gonadotropins (FSH and LH), thereby preventing ovulation and suppressing ovarian activity. Endometrial Transformation: It exerts a profound effect on the uterine lining, transforming the proliferative endometrium into a secretory state and, with continued use, leading to endometrial atrophy, which reduces heavy bleeding. Progestogenic Effect: By maintaining high systemic levels of progestogen, it effectively prevents the decline in hormone levels that would otherwise trigger menstruation, allowing for the postponement of the menstrual period. 3. Administration and Dosing Regimen: Dosage varies significantly based on the indication (e.g., menorrhagia vs. cycle delay). Dosing must be tailored to the patient's cycle and clinical needs. Consistency: For effective cycle control or delay, it is essential to begin treatment at the specified time in the cycle and follow the regimen strictly without missing doses. Administration: Tablets should be taken orally with water, generally at the same time each day to maintain stable hormone concentrations. ⚠️ Safety, Side Effects, and Monitoring Contraindications: Should not be used in patients with a history of thromboembolic disorders (e.g., DVT, pulmonary embolism), severe liver disease, undiagnosed vaginal bleeding, hormone-sensitive malignancies (such as breast cancer), or during pregnancy. Common Side Effects: Breakthrough bleeding or spotting (common during initial cycles), breast tenderness, nausea, fluid retention, headache, weight changes, and mood fluctuations. Monitoring: Patients with conditions potentially aggravated by fluid retention (e.g., asthma, epilepsy, migraine, or cardiac impairment) should be monitored closely. 📦 Storage, Stability & Commercial Packaging Storage: Store at room temperature (below 30°C / 86°F). Protection: Keep in the original blister packaging to protect from moisture, heat, and light. Security: Keep securely out of reach of children. PRESCRIPTION MEDICINE IS: YES. This profile is compiled strictly for international wholesale procurement and commercial educational research. Norethis is a prescription medicine and must be utilized solely under the direct guidance of a registered medical specialist. All cross-border importing setups must comply with the native health authorities of the destination country 📞 Contact Ernest Impex — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Official Websites: www.ernestimpex.com www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com www.ernestvision.com 📧 Corporate Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 📲 WhatsApp Link: https://wa.me/919359902383

Product Profile: Pregaloop (Progesterone Injection IP 100mg/ml) Pregaloop injection contains natural Progesterone in an oil-based vehicle, formulated for intramuscular administration. This preparation is used when oral progesterone is not indicated or when higher bioavailability is required for rapid therapeutic response in reproductive medicine and gynecological care. 1. Clinical Indications & Usage Luteal Phase Support: A standard therapy in Assisted Reproductive Technology (ART) protocols (e.g., IVF) to ensure adequate progesterone levels for implantation and maintenance of early pregnancy. Amenorrhea: Treatment of secondary amenorrhea (the absence of menstrual periods) in non-pregnant, non-nursing women. Abnormal Uterine Bleeding: Used in the management of dysfunctional uterine bleeding due to hormonal imbalance. 2. Mechanism of Action Endometrial Transformation: Progesterone acts on an estrogen-primed endometrium, converting it from a proliferative to a secretory state. This is essential for rendering the uterus receptive to embryo implantation and supporting placental development. Hormonal Feedback: It suppresses the production of gonadotropins (FSH and LH) by the pituitary gland and helps normalize the menstrual cycle. Direct Bioavailability: By bypassing the first-pass metabolism in the liver (which occurs with oral dosing), the injectable form provides direct, reliable systemic availability of the hormone. 3. Administration and Dosing Route: Must be administered by deep intramuscular (IM) injection, typically into the upper outer quadrant of the gluteus muscle. Professional Requirement: This is a professional-grade injectable. Administration must be performed by a qualified healthcare provider under aseptic conditions. Preparation: The oil-based solution should be warmed slightly by rolling the vial between the palms if the medication has thickened, and checked for particulate matter prior to injection. ⚠️ Safety, Side Effects, and Monitoring Contraindications: Do not use if the patient has undiagnosed vaginal bleeding, known hypersensitivity to progesterone, severe liver disease, known or suspected breast or genital cancer, or history of thromboembolic disorders (e.g., DVT, pulmonary embolism). Common Side Effects: Injection site reactions (pain, redness, or swelling), breast tenderness, nausea, fatigue, dizziness, and mood changes. Monitoring: Patients should be monitored for signs of fluid retention, which may exacerbate conditions such as asthma, epilepsy, or migraine. 📦 Storage, Stability & Commercial Packaging Storage: Store at controlled room temperature (20°C to 25°C / 68°F to 77°F). Protection: Keep in original packaging to protect from light. Do not refrigerate or freeze. Security: Keep strictly out of reach of children. PRESCRIPTION MEDICINE IS: YES. Disclaimer: This profile is compiled strictly for international wholesale procurement and commercial educational research. Pregaloop Injection is a prescription medicine and must be utilized solely under the direct guidance of a licensed reproductive endocrinologist or physician. All cross-border importing setups must comply with the native health authorities of the destination country. 📞 Contact Ernest Impex — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Official Websites: www.ernestimpex.com www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com www.ernestvision.com 📧 Corporate Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 📲 WhatsApp Link: https://wa.me/919359902383